tiprankstipranks
Advertisement
Advertisement

BOLT Stock Latest News

Bolt Biotherapeutics Holds 2026 Annual Stockholder Meeting
Company AnnouncementsBolt Biotherapeutics Holds 2026 Annual Stockholder Meeting
2d ago
8K
BOLT
Bolt Biotherapeutics initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Bolt Biotherapeutics initiated with a Buy at Rodman & Renshaw
16d ago
BOLT
Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027
PremiumRatings
Buy Rating on Bolt Biotherapeutics Driven by Differentiated Claudin 18.2 ISAC BDC-4182 and Solid Cash Runway to 2027
3M ago
BOLT
Bolt Biotherapeutics reports Q4 EPS ($3.84), consensus ($5.52)
PremiumThe Fly
Bolt Biotherapeutics reports Q4 EPS ($3.84), consensus ($5.52)
3M ago
BOLT
Buy Rating for Bolt Biotherapeutics: Innovative Approach and Strong Financials Drive Positive Outlook
PremiumRatings
Buy Rating for Bolt Biotherapeutics: Innovative Approach and Strong Financials Drive Positive Outlook
7M ago
BOLT
Bolt Biotherapeutics Reports Improved Financial Performance
PremiumCompany AnnouncementsBolt Biotherapeutics Reports Improved Financial Performance
7M ago
BOLT
Bolt Biotherapeutics reports Q3 EPS ($3.72), consensus ($5.39)
Premium
The Fly
Bolt Biotherapeutics reports Q3 EPS ($3.72), consensus ($5.39)
7M ago
BOLT
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
Premium
Company Announcements
Bolt Biotherapeutics’ Pioneering Study on BDC-4182: A New Hope for Cancer Treatment
8M ago
BOLT
Buy Rating for Bolt Biotherapeutics: Innovative Cancer Treatment Approach and Strategic Financial Management
PremiumRatings
Buy Rating for Bolt Biotherapeutics: Innovative Cancer Treatment Approach and Strategic Financial Management
8M ago
BOLT
Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright
PremiumThe Fly
Bolt Biotherapeutics assumed with a Buy at H.C. Wainwright
8M ago
BOLT
Bolt Biotherapeutics Announces Major Restructuring Plan
PremiumCompany Announcements
Bolt Biotherapeutics Announces Major Restructuring Plan
8M ago
8K
BOLT
Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study
PremiumThe Fly
Bolt Biotherapeutics to reduce workforce by 50%, gives update on BDC-4182 study
9M ago
BOLT
Bolt Biotherapeutics Reports Reduced Losses and Revenue Growth
PremiumCompany AnnouncementsBolt Biotherapeutics Reports Reduced Losses and Revenue Growth
10M ago
BOLT
Cautious Hold Rating on Bolt Biotherapeutics Amid Uncertain Trial Outcomes and Financial Sustainability
Premium
Ratings
Cautious Hold Rating on Bolt Biotherapeutics Amid Uncertain Trial Outcomes and Financial Sustainability
10M ago
BOLT
Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split
Premium
The Fly
Bolt Biotherapeutics target adjusted to $75 at Lake Street after reverse split
10M ago
BOLT
Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)
PremiumThe Fly
Bolt Biotherapeutics reports Q2 EPS ($4.46), consensus ($6.27)
10M ago
BOLT
Bolt Biotherapeutics Inc trading halted, news pending
PremiumThe Fly
Bolt Biotherapeutics Inc trading halted, news pending
1y ago
BOLT
Bolt Biotherapeutics Announces Reverse Stock Split
PremiumCompany Announcements
Bolt Biotherapeutics Announces Reverse Stock Split
1y ago
8K
BOLT
Bolt Biotherapeutics Announces Reverse Stock Split Approval
PremiumCompany Announcements
Bolt Biotherapeutics Announces Reverse Stock Split Approval
1y ago
8K
BOLT
Bolt Biotherapeutics Approves Key Governance Changes
PremiumCompany AnnouncementsBolt Biotherapeutics Approves Key Governance Changes
1y ago
8K
BOLT
Bolt Biotherapeutics initiated with a Buy at Lake Street
Premium
The Fly
Bolt Biotherapeutics initiated with a Buy at Lake Street
1y ago
BOLT
GMAB
Cautious Hold on Bolt Biotherapeutics Amid Awaited Phase 1 Data and Strategic Decisions
Premium
Ratings
Cautious Hold on Bolt Biotherapeutics Amid Awaited Phase 1 Data and Strategic Decisions
1y ago
BOLT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >